Sold Out
Track A (Medlab (Laboratory management - US$ 185) is

This Conference will provide delegates with an opportunity to learn about advances in science and
their application in laboratory medicine that will improve both their practice and patient outcomes.

MEDLAB 2012 is introducing a new track to focus on Histopathology. This track will highlight highend
topics on current trends in histopathology, cytology, immune-histochemistry and molecular
diagnostics for targeted therapies.

MEDLAB Congress is split into the following 6 conference tracks:

• TRACK A - Laboratory Management
• TRACK B - Microbiology
• TRACK C - Histopathology
• TRACK D - Molecular Diagnosis
• TRACK E - Clinical Chemistry
• TRACK F - Haematology

Download the Conference Brochure now!

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation
Council for Continuing Medical Education to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this live activity for a
maximum of 19.25 AMA PRA Category 1 Credits™.

Physicians should claim only the credit commensurate with the extend of
their participation in the activity. Participants claiming CME credit
from this activity may submit the credit hours to the American
Osteopathic Association Council on Continuing Medical Education for Category 2 credit.

Grantor Acknowledgement The Cleveland Clinic Foundation Center for Continuing Education acknowledges educational grants for partial support of this activity from: Platinum Gold Silver

• Recognize the importance of laboratory accreditation and quality assurance in improving laboratory outcomes
• Review the new challenges for laboratory leaders
• Review the new trends in infectious disease management such as the management of emerging transferable multi-drug resistance in GNB
• Appraise new biomics for diagnosis of Tuberculosis
• Discuss the recent advances in laboratory diagnosis of mycoplasma and ureaplasma infections
• Inspect the new development in molecular diagnostics of infectious diseases, transplant infections as well as hepatitis C
• Appraise the use of new molecular diagnostic tools in cancer management
• Describe the current management of haemophilia
• Analyze the current clinical management of haemoglobinoplathy/thalassaemia
• Appraise the current trends in histopathology